Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for bankruptcy protection.
source https://www.seattletimes.com/business/biotechnology-company-regeneron-buying-23andme-for-256-million/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment